Dynavax Technologies (DVAX)

P/S ratio as of February 2026 (TTM): 5.51

According to Dynavax Technologies 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.41. At the end of 2025 the company had a P/S ratio of 3.47.

P/S ratio history for Dynavax Technologies from 2004 to 2025

PS ratio at the end of each year

Year	P/S ratio	Change
2025	3.47	-43.7%
2024	6.16	-20.77%
2023	7.78	314.15%
2022	1.88	-51.09%
2021	3.84	-63.54%
2020	10.5	-22.67%
2019	13.6	-80.59%
2018	70.2	-97.98%
2017	> 1000	25045.31%
2016	13.8	-95%
2015	276	418.98%
2014	53.2	16.11%
2013	45.8	-14.64%
2012	53.6	175.33%
2011	19.5	26.1%
2010	15.4	708.02%
2009	1.91	111.82%
2008	0.9025	-93.74%
2007	14.4	-80.83%
2006	75.2	1006.01%
2005	6.80	-46.81%
2004	12.8

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Pfizer PFE	2.41	-56.19%	🇺🇸 USA
Amgen AMGN	5.60	1.69%	🇺🇸 USA
Biogen BIIB	2.80	-49.19%	🇺🇸 USA
Gilead Sciences GILD	6.47	17.41%	🇺🇸 USA
Merck MRK	4.73	-14.06%	🇺🇸 USA
AstraZeneca AZN	5.47	-0.75%	🇬🇧 UK
GSK plc GSK	2.83	-48.57%	🇬🇧 UK
Agenus AGEN	1.04	-81.05%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	2.29	-58.40%	🇮🇱 Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Dynavax Technologies (DVAX)

P/S ratio as of February 2026 (TTM): 5.51